Efficacy and safety of hyperbaric oxygen therapy monitored by fluorescein angiography in patients with retinal artery occlusion
British Journal of Ophthalmology · 2024
DOI: 10.1136/bjo-2023-323972 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2024. Verfasst von Jeremy Chiabo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Centre Hospitalier Universitaire de Nice, Hôpital Pasteur 2, Nice, France. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Fluorescein Angiography, Retinal Artery Occlusion, Visual Acuity. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
To assess the efficacy and safety of a standardised hyperbaric oxygen therapy protocol (HBOT) monitored by fluorescein angiography (FA) in patients with retinal artery occlusion (RAO).
Methods
It is a prospective, non-comparative, monocentric study conducted between July 2016 and March 2022. All consecutive patients diagnosed with RAO within 7 days underwent visual acuity measurement, FA, macular optical coherence tomography (OCT) and OCT-angiography. They received two daily HBOT sessions (2.5 atmosphere absolute, 90 min) until revascularisation assessed by FA. Complete ophthalmic follow-up was scheduled at day 14, day 21 and at 1 month. The main outcome measure was a best-corrected visual acuity (BCVA) improvement defined as a decrease ≥0.3 logMAR at 1 month.
Results
Thirty-one patients were included and received a mean number of 33.9 (13–56) HBOT sessions. Retinal revascularisation was observed in 48.4% and 87.1% of patients at days 14 and 21, respectively. The mean BCVA on referral and at 1 month was 1.51 logMAR and 1.10 logMAR, respectively. Fifteen (48.4%) patients achieved the main outcome measure. Six (19.4%) patients experienced minor barotrauma that did not require HBOT discontinuation. The univariate analysis showed that antiplatelet-treated patients (p=0.044) and patients with a poor initial BCVA (p=0.008) were more likely to achieve a BCVA improvement. OCT-angiography was not sensitive enough to diagnose RAO or assess revascularisation.
Conclusion
In RAO patients monitored by FA until spontaneous revascularisation of the central retinal artery, HBOT was effective and safe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ophthalmology, Centre Hospitalier Universitaire de Nice, Hôpital Pasteur 2, Nice, France.
- Hyperbaric Oxygen Therapy, Pasteur 2 University Hospital, Nice, France.
- Stroke Unit neurology, Centre Hospitalier Universitaire de Nice Hôpital Pasteur, Nice, France.
- Emergency medicine, Centre Hospitalier Universitaire de Nice, Nice, France.
- Ophthalmology, Centre Hospitalier Universitaire de Nice, Hôpital Pasteur 2, Nice, France baillif.s@chu-nice.fr.
ORCID-Profile: Sacha Nahon-Esteve, Stephanie Baillif
Zitieren
APA
Chiabo, J., Kauert, A., Casolla, B., Contenti, J., Nahon-Esteve, S., Baillif, S., & Arnaud, M. (2024). Efficacy and safety of hyperbaric oxygen therapy monitored by fluorescein angiography in patients with retinal artery occlusion. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2023-323972
Vancouver
Chiabo J, Kauert A, Casolla B, Contenti J, Nahon-Esteve S, Baillif S, et al. Efficacy and safety of hyperbaric oxygen therapy monitored by fluorescein angiography in patients with retinal artery occlusion. British Journal of Ophthalmology. 2024. doi:10.1136/bjo-2023-323972
BibTeX
@article{Chiabo2024,
author = {Chiabo, Jeremy and Kauert, Andreas and Casolla, Barbara and Contenti, Julie and Nahon-Esteve, Sacha and Baillif, Stephanie and Arnaud, Martel},
title = {Efficacy and safety of hyperbaric oxygen therapy monitored by fluorescein angiography in patients with retinal artery occlusion},
journal = {British Journal of Ophthalmology},
year = {2024},
doi = {10.1136/bjo-2023-323972}
}
EUVIMED